Pharma, via its PI Health Sciences arm, now contributes 6% of exports. Q1 FY26 showed a 33% sequential jump in pharma revenues. The management aims to be a differentiated CRDMO player over the next ...

Brokerages predict a challenging period for Tata Motors as India PV/CV and JLR volumes decline. Ebitda margins are under ...